North America Home Infusion Therapy Market Trends, Size, Segment and Growth by Forecast to 2028

 The North America home infusion therapy market is expected to grow from US$ 10,954.08 million in 2022 to US$ 18,112.18 million by 2028. It is estimated to grow at a CAGR of 8.7% from 2022 to 2028.

Increasing Incidences of Chronic Disorders Coupled with Rising Geriatric Population is Driving North America Home Infusion Therapy Market

Chronic disorders such as cardiovascular, nutritional, and gastrointestinal disorders, rheumatoid arthritis, and neurological disorders affect the overall quality of life. According to the World Health Organization (WHO), over 50% of the global population is estimated to suffer from at least one chronic disease. The Centers for Disease Control and Prevention (CDC) stated that 6 out of 10 people in the US suffered from at least one chronic disease in 2019. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” a large-scale multinational study published in 2021, ~40% of 73,076 adults surveyed from 33 countries in the world were suffering from a functional gastrointestinal disorder (GFID). Age-related gastrointestinal problems are more common in the elderly population, aged 64 and above.

📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/BMIRE00028375

Cardiovascular diseases (CVDs), especially the cases associated with hectic lifestyles, are a significant cause of surging mortality. According to the International Diabetes Federation (IDF), 537 million people worldwide, aged 20–79, had diabetes in 2021, and the number is estimated to rise to 783 million by 2045. Additionally, diabetes was the cause of 6.7 million deaths worldwide in 2021. According to the Neurological Alliance, ~14.7 million neurological cases were registered in 2019, with at least 1 in 6 people suffering from 1 or more neurological conditions.

Aging can cause a consistent loss of physiological integrity, resulting in a reduction in functionality and an increased risk of mortality. The degradation of body function is a key risk factor for contracting the majority of chronic diseases, including diabetes, CVD, and neurological diseases, among elderly patients. According to the Global Ageing Survey 2019, the frequency of a person aged 65 or above is likely to increase from 1 in every 11 inhabitants in 2019 to 1 in every 6 inhabitants by 2025. As per the US Census Bureau, the number of Americans with age 65 and above is anticipated to double from 46 million in 2016 to over 98 million by 2060, and the share of the elderly population in the global population will increase from 15% to ~24% in the same period.   

North America Home Infusion Therapy Market Overview 

The North America home infusion therapy market is segmented into the US, Canada, and Mexico. The US held the largest share of the North America home infusion therapy market in 2021. The projected growth of the home infusion therapy market in North America is attributed to the factors such as the presence of leading market players and their product developments, the growing geriatric population, and rising prevalence of diseases and infections. The US holds a significant share of the North America home infusion therapy market. The requirement for home and specialty infusion therapy has increased across the US due to the high prevalence of infections, gastrointestinal diseases & disorders, multiple sclerosis, rheumatoid arthritis, cancer, hemophilia, dehydration, congestive heart failure, immune deficiencies, and neurological disorders. According to a study by National Home Infusion Association (NHIA), in 2019, home infusion and alternate site providers catered to more than 3 million patients in the US, representing a 300% increase since the last industry study in 2008. Furthermore, in 2020, NHIA also estimated that home and specialty infusion comprises over 900 providers serving 3.2 million patients annually in the country. Also, as per the Population Reference Bureau (2019), it is estimated that the geriatric population of the US is expected to grow from 52 million in 2018 to 95 million by 2060. Thus, the presence of leading market players, the growing geriatric population, and the rising prevalence of diseases and infections are expected to increase the demand for home infusion therapy in the coming years. 

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-home-infusion-therapy-market

North America Home Infusion Therapy Market

The North America Home Infusion Therapy Market is undergoing rapid transformation as healthcare systems across the region adapt to new patient needs and cost-efficient treatment models. With an aging population, rising prevalence of chronic diseases, and increasing demand for personalized care, the shift from hospital-based treatments to home-based therapies has become a pivotal trend.

Home infusion therapy involves the administration of medications via needle or catheter in a patient’s home. It encompasses a range of treatments including antibiotics, antivirals, pain management drugs, nutrition therapy, and chemotherapy. The convenience, comfort, and cost-effectiveness associated with home care have been major drivers propelling the North America Home Infusion Therapy Market.

One of the key advantages of this market is its ability to reduce the burden on healthcare facilities. Hospitals and outpatient centers can become overwhelmed with chronic care patients, especially those requiring long-term intravenous therapy. By moving such treatments to a home setting, healthcare providers can optimize resources while ensuring patients receive timely and effective care. This model significantly supports the overall efficiency of the healthcare system, further accelerating the growth of the North America Home Infusion Therapy Market.

Technological advancements in infusion pumps and remote monitoring systems are also reshaping the market landscape. Smart devices allow healthcare professionals to monitor patients’ therapy in real time, reducing complications and ensuring medication adherence. These innovations are crucial for maintaining the safety and effectiveness of treatments administered outside traditional clinical settings. As such, the North America Home Infusion Therapy Market is closely tied to the evolution of medical technologies and telehealth solutions.

Regulatory support and reimbursement policies across North America have further boosted the market. Governments and insurance providers are increasingly recognizing the cost-saving potential of home-based care, and many are expanding coverage for home infusion services. This favorable policy environment is encouraging more healthcare providers to offer infusion therapies at home, thereby driving the North America Home Infusion Therapy Market forward.

Moreover, patient preferences are playing a major role in the market’s expansion. Individuals with chronic illnesses often face reduced mobility and prefer treatment options that allow them to stay within the comfort of their homes. The emotional and psychological benefits of receiving care in a familiar setting cannot be overstated. This patient-centric approach is a cornerstone of the North America Home Infusion Therapy Market, aligning healthcare delivery with modern expectations.

Despite its growth potential, the market also faces challenges such as maintaining consistent quality of care, managing logistics, and addressing staffing shortages in home healthcare. Nonetheless, the long-term outlook remains positive. Continued investments in infrastructure, training, and technology are expected to mitigate these barriers and further enhance the efficiency of home-based infusion services.

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

1. Braun Melsungen AG

Baxter International Inc

Nipro Corp

Becton Dickinson and Co

Fresenius Kabi AG

ICU Medical Inc

JMS Co Ltd

Eitan Medical Ltd

Terumo Corp

In conclusion, the North America Home Infusion Therapy Market represents a dynamic and promising sector in the region’s healthcare ecosystem. With strong demand drivers, technological innovation, and policy support, the market is well-positioned for sustained growth. As the healthcare landscape continues to evolve, the North America Home Infusion Therapy Market will play a critical role in shaping the future of patient care across the continent.

The North America home infusion therapy market has experienced considerable growth in recent years, driven by the rising prevalence of chronic diseases, an aging population, and an increasing demand for cost-effective and convenient healthcare alternatives. Home infusion therapy refers to the administration of medications through a needle or catheter in a patient’s home, often including treatments such as antibiotics, antivirals, parenteral nutrition, hydration therapy, pain management, and chemotherapy.

Rising Burden of Chronic Diseases

Chronic diseases such as cancer, diabetes, congestive heart failure, and immune deficiencies are becoming more prevalent across North America. These conditions often require long-term, continuous treatment that can be effectively managed through home infusion therapy. For instance, diabetic patients may need regular infusion of insulin or other related therapies, while cancer patients often require chemotherapy and pain management infusions. Home-based treatment provides a safe and comfortable alternative to hospital visits, especially for patients with mobility limitations or compromised immune systems.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

You can see this-

Europe Nutraceuticals Market- https://businessmarketresportsnews.blogspot.com/2025/04/europe-nutraceuticals-market-trends_21.html

Europe Biopsy Devices Market- https://sites.google.com/view/bmi237/home

Europe Silicon Anode Battery Market- https://postyourarticle.com/europe-silicon-anode-battery-market-key-players-analysis-opportunities-and-growth-forecast-to-2027/